It is impossible to come up with a universal definition of premature ejaculation because so much variation exists among individuals. I have met women who are perfectly satisfied with intercourse that lasts two or three minutes, while others are frustrated when their partners cannot last more than fifteen or twenty. Do you and your partner feel that you reach orgasm too quickly? If so, there are many practical steps you can take to solve the problem. Continue Reading
Testicular cancer, which affects mainly younger men, is relatively rare. This form of cancer is the most easily treated of all tumors in the genitourinary system. Just a few decades ago, more than 90 percent of patients with certain types of testicular cancer did not survive five years. Today a majority of cases are curable. Continue Reading
Not all patients diagnosed with prostate cancer are candidates for surgical removal of the prostate gland. Those who are will benefit greatly from the da Vinci robot-assisted prostatectomy, now widely performed at most major hospitals throughout the United States. Continue Reading
President Barack Obama recently received a PSA (prostate-specific antigen) test to screen for prostate cancer during his yearly physical examination. Dr. Jeffrey C. Kuhlman, White House physician, released a report dated October 31, 2011, which said that the test was performed after the president made an “informed patient request.” Continue Reading
For those men diagnosed with “aggressive”, organ-confined carcinoma of the prostate, and who are candidates for surgery, the robotic-assisted laparoscopic prostatectomy is now the Gold Standard. Continue Reading
Based on my more than 35 years of experience in urologic oncology, and having treated more than 10,000 men with prostate cancer, I recommend that if you are a male between 40 and 70 years old, you should get an annual prostate-specific antigen (PSA) blood screening test and a digital rectal exam (DRE). Continue Reading
As mentioned in my last post “Controversy Over a PSA Blood Test” a virtual firestorm has erupted with the publication of the US Preventive Services Task Force draft recommendation that healthy men should no longer receive a PSA (prostate-specific antigen) blood test to screen for prostate cancer because “the test does not save lives overall and often leads to more tests and treatments that needlessly cause pain, impotence, and incontinence,” according to a recent NY Times article.
Controversy over a Key Prostate Cancer Screening Blood Test (PSA): The Real Story
Earlier this month, the US Preventive Services Task Force recommended that healthy men should no longer receive a PSA (prostate-specific antigen) blood test to screen for prostate cancer as part of routine cancer screening. This has created an uproar in both the urologic community and the medical community at large. It is a decision made by a panel that does not include a urologist or an oncologist. Continue Reading
IT’S A REAL DEAL: FREE PROSTATE CANCER SCREENING EXAM
September was Prostate Cancer Awareness Month, and most hospitals, whether they are community hospitals, for-profit hospitals, or university hospitals, were offering free prostate cancer screening examinations throughout the month. This is not only a good deal but a big deal, as more than 240,000 new cases of prostate cancer will be diagnosed in the United States in 2011, according to the National Cancer Institute. In this country, prostate cancer is the most common cancer diagnosed in males and the second most common cause of death in men from all cancers. The importance of screening and early diagnosis cannot be emphasized enough. Early diagnosis and treatment are the key to a cure and long-term survival.
STAXYN—A NEW DRUG FOR THE TREATMENT OF ERECTILE DYSFUNCTION
A new drug that has a unique mode of administration has just been released on the market for erectile dysfunction (ED). Best described as a “breath mint,” the tablet is merely placed on the tongue and dissolves in about one minute—no chewing, no swallowing, no absorption through the stomach or intestine.